Highlights
● Severe acute respiratory syndrome coronavirus 2–related coronavirus GX/P2V/2017 infects mice with moderate pathogenicity.
● ZF2001 vaccination protects mice against GX/P2V/2017 infection.
● Sera from people vaccinated with ZF2001 cross-react and cross-neutralize GX/P2V/2017.